Search

everythinglearnresearchcommunity

for

Search:↓

PRP therapy can temporarily grow hair in CCCA patients but isn't a permanent cure.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Alopecia areata involves unique activation of certain immune cells.

SCDSFs from zebrafish embryos are beneficial for treating cancer, regenerating tissues, and improving conditions like psoriasis and alopecia.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Surgical methods like suction blister grafting and split-thickness skin grafting are highly successful for vitiligo repigmentation, but choosing the right patients is crucial for success.

Mesenchymal stem cell therapy shows promise for treating certain inflammatory skin diseases, but more research is needed.

Using fat-derived stem cells for hair loss treatment is safe and effective, improving hair growth and patient satisfaction.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Cyclosporine effectively treated a woman's stubborn skin condition.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

A rare skin infection in a 10-year-old kidney transplant patient was successfully managed by adjusting medication.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Genetically modified cells can regenerate skin and hair in rats.

Photodynamic therapy successfully treated a difficult scalp condition causing hair loss.

Genetically modified stem cells from human hair follicles can lower blood sugar and increase survival in diabetic mice.

Hair cell cloning could potentially rejuvenate shrinking hair follicles, allowing for lifelong hair maintenance.

Stem cells in the cornea show unexpected flexibility and have important implications for medicine.

Combination therapy effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

Stem cells rearrangement regenerates functional hair follicles, potentially treating hair loss.

All-trans retinoic acid helps amelanotic melanocytes in hair follicles develop and produce pigment while reducing their growth.

Platelet-rich plasma and stem cell therapies are accepted treatments for hair restoration, with specific protocols recommended for best results, but more standardization is needed in stem cell use.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Advancements in skin treatment and wound healing include promising gene therapy, 3D skin models, and potential new therapies.

Transplanting body hair helped repigment and treat a man's vitiligo.

Nanomedicine-based immunotherapy shows promise in improving tissue repair and regeneration.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.